Lakeland Regional Hospital
Lakeland, Florida, 33805, United States
Location status: Recruiting
NCT Number: NCT07263035
The goal of this clinical trial is to learn if increasing the dose of diuretics to achieve a higher urine sodium target produces better clinical results when treating patients hospitalized with acute heart failure when compared to lower urine sodium target and standard of care.
The main questions it aims to answer are:
1. Does targeting a higher urine sodium goal achieve greater natriuresis and diuresis? 2. Does targeting a higher urine sodium goal reduce frequency of hospital readmissions? 3. Does targeting a higher urine sodium goal reduce hospital length of stay?
Researchers will compare natriuresis-guided arms with standard of care to see if targeting higher natriuresis goals improves significantly over current practice.
Participants will submit urine samples at routine intervals after being given diuretics to evaluate urine sodium concentration. If urine sodium is low then diuretic dose will be increased.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Phase 4
Lakeland, Florida, 33805, United States
Location status: Recruiting
Patients will be randomized into one of three groups: 50 micromolar natriuresis, 85 micromolar natriuresis, and standard of care. The natriuresis arms will have urine sodium assessed two to four hours administration of intravenous diuretics. If the natriuretic response is inadequate they will immediately receive a higher dose of diuretic. This process will be repeated for the first 72 hours of admission.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Diuretics will be titrated to achieve a urine sodium concentration of 50 mmol/L
Other names: Lasix
Time frame: 24 hours
24-hour natriuresis as measured by urine sodium in a 24-hour urine collection
Time frame: 48 hours after enrollment in trial
Total urine sodium assessed by 24-hour urine collection
Time frame: 24 hours after enrollment
Total urine volume assessed by 24 hour collection
Time frame: 48 hours after enrollment
Total urine volume assessed via 24-hour collection
Time frame: From the date and time of admission order until the date and time of discharge order, assessed for each participant up to 30 days after admission or death from any cause, whichever comes first.
Duration of hospitalization
Time frame: 30 days after discharge
Proportion of participants who experience an unplanned hospital readmission for any cause within 30 days after the index hospital discharge.
Time frame: 90 days after the time of discharge
Proportion of participants who experience an unplanned hospital readmission for any cause within 90 days after the index hospital discharge.
Time frame: 30 days
Proportion of participants who experience an unplanned hospital readmission specifically for heart failure within 30 days after the index hospital discharge.
Time frame: 90 days
Proportion of participants who experience an unplanned hospital readmission specifically for heart failure within 90 days after the index hospital discharge.
Time frame: Weight assessed at baseline within 24 hours of hospital admission and at discharge, with the discharge weight measured on the discharge day up to 30 days after admission.
Difference in weight from admission compared to discharge
Time frame: Net fluid balance assessed from baseline Day 1 of admission through hospital discharge, with discharge assessment on the discharge day up to 30 days after admission.
Cumulative difference between total fluid intake and output during the hospitalization
Contact information is provided by the study sponsor or research team.
Lakeland Regional Health Systems, Inc.
Other
Acronym: US-DASH
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07447908
Apple Watch, Cardiopulmonary Exercise Test
Newmarket, Ontario, Canada
View Trial DetailsNCT07530029
Acute Heart Failure (AHF), Atrophy
Madrid, Spain
View Trial DetailsNCT07527156
Acid-Base Imbalance, Acidosis
Prague, Czechia
View Trial DetailsNCT06885164
Cardiovascular Diseases, Heart Diseases
Aalborg, Denmark
View Trial Details